Dava Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DAVA PHARMS INC, and what generic and branded alternatives to DAVA PHARMS INC drugs are available?
DAVA PHARMS INC has forty-five approved drugs.
Drugs and US Patents for Dava Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dava Pharms Inc | NAPROXEN | naproxen | TABLET;ORAL | 074105-002 | Dec 21, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Dava Pharms Inc | CAPTOPRIL | captopril | TABLET;ORAL | 074423-004 | Feb 13, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Dava Pharms Inc | METHYLDOPA AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; methyldopa | TABLET;ORAL | 072509-001 | Jun 2, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.